Acute Leukemias: Mastering the Latest Developments in the Absence of Targetable Mutations

Gain insights into the latest advances in the use of new approaches for treating patients with ALL and AML including biomarkers new targeted agents safety considerations and clinical trials through expert-guided discussion and case-based examples.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.